Literature DB >> 10843874

Ischemic preconditioning prevents I/R-induced alterations in SR calcium-calmodulin protein kinase II.

M Osada1, T Netticadan, K Kawabata, K Tamura, N S Dhalla.   

Abstract

Although Ca(2+)/calmodulin-dependent protein kinase II (CaMK II) is known to modulate the function of cardiac sarcoplasmic reticulum (SR) under physiological conditions, the status of SR CaMK II in ischemic preconditioning (IP) of the heart is not known. IP was induced by subjecting the isolated perfused rat hearts to three cycles of brief ischemia-reperfusion (I/R; 5 min ischemia and 5 min reperfusion), whereas the control hearts were perfused for 30 min with oxygenated medium. Sustained I/R in control and IP groups was induced by 30 min of global ischemia followed by 30 min of reperfusion. The left ventricular developed pressure, rate of the left ventricular pressure, as well as SR Ca(2+)-uptake activity and SR Ca(2+)-pump ATPase activity were depressed in the control I/R hearts; these changes were prevented upon subjecting the hearts to IP. The beneficial effects of IP on the I/R-induced changes in contractile activity and SR Ca(2+) pump were lost upon treating the hearts with KN-93, a specific CaMK II inhibitor. IP also prevented the I/R-induced depression in Ca(2+)/calmodulin-dependent SR Ca(2+)-uptake activity and the I/R-induced decrease in the SR CaMK II activity; these effects of IP were blocked by KN-93. The results indicate that IP may prevent the I/R-induced alterations in SR Ca(2+) handling abilities by preserving the SR CaMK II activity, and it is suggested that CaMK II may play a role in mediating the beneficial effects of IP on heart function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843874     DOI: 10.1152/ajpheart.2000.278.6.H1791

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

1.  Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia.

Authors:  J C S Ho; S Wu; K W L Kam; J S K Sham; T M Wong
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor.

Authors:  Ibrahim F Benter; Jasbir S Juggi; Islam Khan; Mariam H M Yousif; Halit Canatan; Saghir Akhtar
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats.

Authors:  Qiufang Zhang; Jizhou Xiang; Xuanbin Wang; Hui Liu; Benrong Hu; Mei Feng; Qin Fu
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 4.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

5.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

6.  Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.

Authors:  Cecilia Mundiña-Weilenmann; Matilde Said; Leticia Vittone; Paola Ferrero; Alicia Mattiazzi
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

7.  Enhanced KCl-mediated contractility and Ca2+ sensitization in porcine collateral-dependent coronary arteries persist after exercise training.

Authors:  Cristine L Heaps; Jeff F Bray; Janet L Parker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-28       Impact factor: 4.733

8.  Inhibition of Ras-GTPase, but not tyrosine kinases or Ca2+/calmodulin-dependent protein kinase II, improves recovery of cardiac function in the globally ischemic heart.

Authors:  Ibrahim F Benter; Jasbir S Juggi; Islam Khan; Saghir Akhtar
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

Review 9.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

10.  At-risk but viable myocardium in a large animal model of non ST-segment elevation acute coronary syndrome: cardiovascular magnetic resonance with ex vivo validation.

Authors:  Henry Chang; Tam Tran; George E Billman; Mark W Julian; Robert L Hamlin; Orlando P Simonetti; Giuseppe Ambrosio; Peter B Baker; Guohong Shao; Elliott D Crouser; Subha V Raman
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.